[Remote] (Senior) Medical Science Liaison- Central Midwest at Tempus

Minnesota, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, Precision MedicineIndustries

Skills

Key technologies and capabilities for this role

OncologyGenomic TestingClinical DataScientific DataMarket IntelligenceCommunication SkillsPresentation Skills

Questions & Answers

Common questions about this position

What is the location for this Medical Science Liaison role?

This is a field-based role covering the Midwest region, specifically MN, IA, and ND.

What education and experience are required for this position?

An advanced scientific or medical degree such as PhD, PharmD, MD, MSN, or BSN is required, along with a basic understanding of oncology. Preferred qualifications include 1+ years of MSL experience in diagnostics, biotech, or pharmaceutical industries.

What key skills are needed for the MSL role?

Candidates need a fundamental understanding of molecular oncology, existing KOL relationships in oncology, working knowledge of genomic LDT, public speaking skills, exceptional interpersonal communication, and strong management skills. They must also be self-starters able to travel up to 50%.

Is travel required for this position?

Yes, the role requires the ability to travel up to 50%.

What makes a strong candidate for this MSL position?

A strong candidate has an advanced degree in science or medicine, oncology expertise, existing KOL relationships, MSL experience in diagnostics or biotech, and excellent communication and public speaking skills.

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free